The Indian pharma sector stocks showed mixed performance as of 10:22 AM IST on January 21, 2026. Broader market context includes the S&P BSE Sensex at 81,893.19 (-0.35%) and Nifty 50 at 25,144.45 (-0.35%).

Key Observations from Pharma Stocks Data (as of 10:22 AM)

  • Gainers: Several stocks posted positive changes, including:
    • Senores Pharmaceuticals Ltd.: +2.34% (BSE) / +1.79% (NSE)
    • Sudeep Pharma Ltd.: +2.46% (BSE) / +1.43% (NSE)
    • Indegene Ltd.: +1.89% (BSE) / +1.26% (NSE)
    • Natco Pharma: +1.75% (BSE) / +1.70% (NSE)
    • Lupin: +1.08% (BSE) / +0.76% (NSE)
    • Zydus Lifesciences: +1.06% (BSE) / +0.78% (NSE)
    • Eris Lifesciences: +1.03% (BSE) / +0.45% (NSE)
    • Sun Pharma: +0.81% (both BSE and NSE)
    • Ajanta Pharma: +0.86% (BSE) / +0.75% (NSE)
    • Glenmark Pharma: +0.67% (BSE) / +0.43% (NSE)
  • Losers: Many stocks declined, with notable drops in:
    • Jubilant Industries: -4.08% (BSE) / -4.46% (NSE)
    • Onesource Specialty Pharma Ltd.: -3.51% (BSE) / -3.76% (NSE)
    • Suven Life Sciences: -3.59% (both)
    • Corona Remedies Ltd.: -3.36% (BSE) / -3.00% (NSE)
    • Strides Pharma Science: -2.24% (BSE) / -3.33% (NSE)
    • Thyrocare Technologies: -2.25% (BSE) / -2.54% (NSE)
    • Wyeth (notable discrepancy in NSE change, possibly data error): -2.27% (BSE)
    • Neuland Labs: -1.61% (BSE) / -1.98% (NSE)
  • Major Large-Cap Pharma Stocks:
    • Sun Pharma: 1,625.00 (+0.81%)
    • Divi’s Laboratories: 6,036.25 (+0.44%)
    • Cipla: 1,381.25 (+0.25%)
    • Dr. Reddy’s Lab: 1,169.15 (+0.19%)
    • Torrent Pharma: 3,988.00 (+0.33%)
    • Lupin: 2,189.40 (+1.08%)

This summary is based on the provided snapshot at 10:22 AM IST. For real-time updates, refer to official stock exchange platforms like NSE or BSE.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.